Skip to main content
. 2020 Oct 14;12(10):3137. doi: 10.3390/nu12103137

Table 2.

Clinical characteristics according to the improvement of nitrogen balance.

Improvement of Nitrogen Balance (n = 39, 50.6%) No Improvement/Aggravation of Nitrogen Balance (n = 38, 49.4%) p-Value
Age (years), mean ± SD 62.7 ± 15.1 58.6 ± 17.5 0.273
Male, n (%) 21 (53.8) 20 (52.6) 0.915
BMI (Kg/m2), mean ± SD 22.1 ± 4.2 23.0 ± 3.9 0.375
HT, n (%) 16 (41.0) 19 (50.0) 0.429
DM, n (%) 7 (17.9) 11 (28.9) 0.254
HL, n (%) 5 (12.8) 5 (13.2) 1.000
CAD, n (%) 3 (7.7) 2 (5.3) 1.000
A. fib, n (%) 5 (12.8) 5 (13.2) 1.000
Previous stroke/TIA, n (%) 12 (30.8) 3 (7.9) 0.011
Cancer, n (%) 3 (7.7) 5 (13.2) 0.481
GI diseases, n (%) 1 (2.6) 1 (2.6) 1.000
Initial GCS, median (IQR) 6.0 (5–11) 6.5 (5–11.25) 0.750
F/U GCS, median (IQR) 9.0 (6.0–13.0) 7.0 (3–12.25) 0.075
APACHE II score, median (IQR) 25 (21–28) 26 (21.5–28.5) 0.478
NUTRIC score, median (IQR) 4 (3–5) 4 (3–5) 0.343
Nutritional support, n (%) 39 (97.4) 34 (89.5) 0.200
Initial protein balance (g/day), mean ± SD −58.3 ± 40.6 −55.7 ± 40.7 0.782
Initial negative nitrogen balance, n (%) 36 (92.3) 35 (92.1) 1.000
% of IBW, mean ± SD 105.7 ± 21.3 110.8 ± 21.1 0.289
Body weight loss, n (%) 17 (43.6) 19 (50.0) 0.573
Total I/O, mean ± SD 1742.3 ± 3630.6 1658.8 ± 2384.7 0.906
Negative I/O, n (%) 12 (30.8) 9 (23.7) 0.485
Diagnosis, n (%) 0.445
IS 10 (25.6) 5 (13.2)
SAH 10 (25.6) 8 (21.1)
SDH 6 (15.4) 8 (21.1)
ICH 6 (15.4) 8 (21.1)
SE 2 (5.1) 1 (2.6)
Others 5 (12.8) 11 (28.9)
Initial Nutrition supplement, n (%) 0.077
NPO 8 (20.5) 13 (34.2)
EN 27 (69.2) 25 (65.8)
PN 4 (10.3) 0 (0.0)
F/U Nutrition supplement, n (%) 0.341
EN 17 (43.6) 23 (60.5)
PN 3 (7.7) 3 (7.9)
EN with PN 19 (48.7) 12 (31.6)
Protein intake on admission (g/kg), mean ± SD 0.66 ± 0.56 0.54 ± 0.48 0.289
Calorie intake on admission (kcal/kg), mean ± SD 12.0 ± 10.1 10.4 ± 9.00 0.455
Protein intake on follow up (g/kg), mean ± SD 1.94 ± 0.63 1.28 ± 0.54 <0.001
Calorie intake on follow up (kcal/kg), mean ± SD 25.3 ± 7.5 21.5 ± 7.9 0.037
Initial BUN (mg/dl), mean ± SD 16.3 ± 8.3 16.0 ± 10.1 0.885
F/U BUN (mg/dl), mean ± SD 23.9 ± 9.6 22.9 ± 11.8 0.692
Initial Creatinine (mg/dl), mean ± SD 0.64 ± 0.30 0.71 ± 0.43 0.389
F/U Creatinine (mg/dl), mean ± SD 0.62 ± 0.39 0.68 ± 0.49 0.551
Event, n (%) 0.348
Coma therapy 2 (5.1) 3 (7.9)
TTM 2 (5.1) 3 (7.9)
Decompressive surgery 6 (15.4) 2 (5.3)
Decompressive surgery with TTM 1 (2.6) 5 (13.2)
Others 2 (5.1) 3 (7.9)
Blood transfusion, n (%) 0.115
Packed red blood cell 0 (0.0) 3 (7.9)
Sepsis during ICU care, n (%) 5 (12.8) 3 (7.9) 0.711
ARDS during ICU care, n (%) 5 (12.8) 2 (5.3) 0.431
Development of AKI, n (%) 3 (7.7) 2 (5.3) 1.000
NICU admission to initial UUN day, median (IQR) 1 (1–2.3) 1.5 (1–2) 0.805
NICU admission to F/U UUN day, median (IQR) 6 (5–9) 7 (4–8) 0.692
Good outcome at 3 months (mRS = 0–3), n (%) 16 (41.0) 7 (18.4) 0.046
Neurological worsening, n (%) 6 (15.4) 14 (36.8) 0.032
In-hospital mortality, n (%) 5 (12.8) 12 (31.6) 0.047
Hospital length of stay (days), median (IQR) 38.0 (25.0–75.0) 33.5 (23.0–67.25) 0.610
NICU length of stay (days), median (IQR) 18.0 (10.0–32.0) 20.50 (13.75–33.25) 0.815

BMI: body mass index, HT: hypertension, DM: diabetes mellitus, HL: hyperlipidemia, CAD: coronary artery disease, A. fib: atrial fibrillation, TIA: transient ischemic attack, GI: gastrointestinal, GCS: Glasgow Coma Scale, F/U: follow up, IBW: ideal body weight, I/O: input/output, IS: ischemic stroke, SAH: subarachnoid hemorrhage, SDH: subdural hemorrhage, ICH: intracerebral hemorrhage, SE: status epilepticus, NPO: nil per os, EN: enteral nutrition, PN: parenteral nutrition, BUN: blood urea nitrogen, ARDS: acute respiratory distress syndrome, AKI: acute kidney injury, mRS: modified Rankin Scale, TTM: targeted temperature management, UUN: urine urea nitrogen, IQR: interquartile range, NICU: neurointensive care unit.